ciprofloxacin has been researched along with Dilatation, Pathologic in 3 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Dilatation, Pathologic: The condition of an anatomical structure's being dilated beyond normal dimensions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate whether 1 week of ciprofloxacin before percutaneous nephrolithotomy (PCNL) in patients with stones of > or = 20 mm or pelvicalyceal dilatation, reduces urosepsis, as we previously reported that such patients have four times the risk of urosepsis after PCNL." | 9.12 | One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. ( Mariappan, P; Moussa, SA; Smith, G; Tolley, DA, 2006) |
| "This study investigates the potential benefits of antibiotics and N-acetylcysteine (NAC), a mucolytic agent, in patients who are candidates for endoscopic retrograde cholangiopancreatography (ERCP) due to partial bile duct obstruction." | 5.14 | Potential benefits of combined N-acetylcysteine and ciprofloxacin therapy in partial biliary obstruction. ( Akkiz, H; Cosar, A; Kece, C; Ozdil, B; Sandikci, M, 2010) |
| "To evaluate whether 1 week of ciprofloxacin before percutaneous nephrolithotomy (PCNL) in patients with stones of > or = 20 mm or pelvicalyceal dilatation, reduces urosepsis, as we previously reported that such patients have four times the risk of urosepsis after PCNL." | 5.12 | One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. ( Mariappan, P; Moussa, SA; Smith, G; Tolley, DA, 2006) |
| "Ciprofloxacin accelerates aortic root enlargement and increases the incidence of aortic dissection and rupture in Marfan mice, partially by suppressing lysyl oxidase expression and further compromising the inherited defect in aortic elastic fibers." | 4.12 | Ciprofloxacin accelerates aortic enlargement and promotes dissection and rupture in Marfan mice. ( Barrish, JP; Coselli, JS; LeMaire, SA; Luo, W; Shen, YH; Zhang, L; Zhang, NS; Zhang, Q, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| LeMaire, SA | 1 |
| Zhang, L | 1 |
| Zhang, NS | 1 |
| Luo, W | 1 |
| Barrish, JP | 1 |
| Zhang, Q | 1 |
| Coselli, JS | 1 |
| Shen, YH | 1 |
| Ozdil, B | 1 |
| Kece, C | 1 |
| Cosar, A | 1 |
| Akkiz, H | 1 |
| Sandikci, M | 1 |
| Mariappan, P | 1 |
| Smith, G | 1 |
| Moussa, SA | 1 |
| Tolley, DA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neutrophil and Lymphocyte Counts and the Neutrophil-to-lymphocyte Ratio as a Predictor of Fever Following Percutaneous Nephrolithotomy in Patients Without Risk Factors[NCT03774940] | 519 participants (Actual) | Interventional | 2005-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for ciprofloxacin and Dilatation, Pathologic
| Article | Year |
|---|---|
Potential benefits of combined N-acetylcysteine and ciprofloxacin therapy in partial biliary obstruction.
Topics: Acetylcysteine; Aged; Anti-Infective Agents; Bile Ducts; Bilirubin; C-Reactive Protein; Cholangiopan | 2010 |
One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Dilatation, Pathologic; Female | 2006 |
1 other study available for ciprofloxacin and Dilatation, Pathologic
| Article | Year |
|---|---|
Ciprofloxacin accelerates aortic enlargement and promotes dissection and rupture in Marfan mice.
Topics: Animals; Anti-Bacterial Agents; Aorta; Aortic Aneurysm; Aortic Dissection; Aortic Rupture; Apoptosis | 2022 |